AIDX 20/20 Biolabs, Inc.
Company Analysis
Latest News
🟢 20/20 Biolabs is trading 6.46% up today
20/20 Biolabs is trading at $0.27, up 6.46%, with no clear company-specific catalyst identified for the October 23 move. - Available searches found no...
🔴 20/20 Biolabs is trading 5.4% down today amid broader risk-off pressure
20/20 Biolabs is trading at $0.26, down 5.42%, with broader risk-off pressures the likeliest available context for the decline—not a confirmed company-specific...
🟢 20/20 Biolabs is trading 5.6% up
20/20 Biolabs is trading 5.62% higher at $0.28 amid a broader biotech rally; no clear company-specific announcement explaining the October 21 move surfaced in...
🟢 20/20 Biolabs is trading 6.84% up in after-hours trading, with no clear company-specific catalyst identified
20/20 Biolabs is trading at $0.28, up 6.84% after the October 19, 2026 regular session; biotech-sector gains offer context, but no company-specific catalyst...
🟢 20/20 Biolabs is trading 13% up today as biotech sector gains 2.09%
20/20 Biolabs is trading at $0.29, up 12.78%, with biotech-sector gains providing the more relevant support. - The biotech sector is up 2.09%; the broader...
🔴 20/20 Biolabs is trading 5.9% down today amid biotech sector weakness
20/20 Biolabs is trading at $0.26, down 5.9%, with biotech-sector weakness likely contributing to the decline. - Biotech, represented by XBI, was down 2.06%...
🟢 20/20 Biolabs is trading 7.1% up in pre-market
20/20 Biolabs is trading 7.1% higher at $0.30 in pre-market, rebounding after several consecutive declining closes. - The October 15 close was $0.28. - No...
🟢 20/20 Biolabs is trading 11.9% up in after-hours trading with no identified company-specific catalyst
20/20 Biolabs is trading 11.9% up in after-hours at $0.31, versus the October 15 regular-session close of $0.28; its catalyst remains uncertain. - The latest...
🔴 20/20 Biolabs is trading 10.4% down today as hotter producer prices intensify rate concerns
20/20 Biolabs is trading 10.4% down at $0.28, as broader inflation concerns weigh on risk sentiment. - No company-specific announcement explaining the October...
🔴 20/20 Biolabs is trading 7.1% down today amid inflation concerns after producer prices surged
20/20 Biolabs is trading at $0.29, down 7.11%, as broader inflation concerns pressure risk sentiment. - No company-specific announcement explaining the...
🔴 20/20 Biolabs is trading 10.25% down today as hotter-than-expected inflation pressures growth shares
20/20 Biolabs is trading 10.25% lower at $0.32, with the broader market selloff the most likely explanation following hotter-than-expected inflation. -...
🔴 20/20 Biolabs is trading 5% down today amid hotter-than-expected inflation and U.S. stock losses
20/20 Biolabs is trading at $0.33, down 5.35% on October 14, 2026, amid broader market weakness; no new company-specific announcement explaining the decline...
🟢 20/20 Biolabs is trading 7.1% up in pre-market
20/20 Biolabs is trading 7.1% higher at $0.38 in pre-market, with the reason for the gain still uncertain. - On October 2, the company announced that its CEO...
🟢 20/20 Biolabs is trading 11.48% up in after-hours trading — catalyst remains unidentified
20/20 Biolabs is trading 11.48% up at $0.41 in after-hours trading; the catalyst remains unidentified. - No verified company-specific announcement on October...
🟢 20/20 Biolabs is trading 5.8% up
20/20 Biolabs is trading 5.8% higher at $0.40, with no verified company-specific or market-wide explanation identified for the October 12 move. - The latest...
🟢 20/20 Biolabs is trading 7.1% up in pre-market
20/20 Biolabs is trading 7.1% higher at $0.40 versus the previous close, with no verified company-specific catalyst identified for the October 12 pre-market...
🟢 20/20 Biolabs is trading 6.7% up in after-hours trading — no confirmed catalyst identified
20/20 Biolabs is trading 6.7% higher at $0.40 in after-hours trading, with no verified company-specific catalyst identified for the October 9 move. - The...
🟢 20/20 Biolabs is trading 11.6% up as no clear catalyst is identified
20/20 Biolabs is trading 11.6% up at $0.38 on October 8, 2026, with no verified company-specific announcement or event explaining the move. - The October 7...
🟢 20/20 Biolabs is trading 8.6% up; catalyst remains unclear
20/20 Biolabs is trading 8.55% higher at $0.37, with no verified catalyst identified for the October 8 move. - The October 7 investor webinar was announced in...
🟢 20/20 Biolabs is trading 9.7% up in pre-market
20/20 Biolabs is trading at $0.38, up 9.66% in pre-market; the move’s cause remains unclear. - No clear company-specific catalyst was identified for the...